{"text": ["Big", "Pharma", "kills", "signature", "drug", "at", "center", "of", "$5.8", "billion", "South", "S.F.", "deal"], "created_at": "2019-08-29 21:18:11"}
{"text": ["Health", "Care", "Sector", "Update", "for", "08/29/2019:", "AZN,", "ABBV,", "IBIO"], "created_at": "2019-08-29 18:00:10"}
{"text": ["Health", "Care", "Sector", "Update", "for", "08/29/2019:", "AZN,", "ABBV,", "IBIO"], "created_at": "2019-08-29 18:00:10"}
{"text": ["UPDATE", "1-AbbVie", "abandons", "late-stage", "lung", "cancer", "asset", "Rova-T"], "created_at": "2019-08-29 13:35:41"}
{"text": ["AbbVie", "Discontinues", "Phase", "III", "Trial", "of", "Drug", "to", "Treat", "Small-Cell", "Lung", "Cancer"], "created_at": "2019-08-29 13:29:00"}
{"text": ["AbbVie", "is", "shutting", "down", "its", "troubled", "Rova-T", "R&D", "program"], "created_at": "2019-08-29 13:16:00"}
{"text": ["AbbVie", "terminates", "late-stage", "lung", "cancer", "trial"], "created_at": "2019-08-29 12:59:20"}
{"text": ["AbbVie", "Discontinues", "Rovalpituzumab", "Tesirine", "(Rova-T)", "Research", "and", "Development", "Program"], "created_at": "2019-08-29 12:45:00"}
